Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intelligent Tissue Group is a UK life sciences services company focused on ethical human biomaterial procurement and tissue-based research services for drug discovery and development. The group was incorporated in 2015 and built a multi-business offering that included Tissue Solutions, a virtual biobank supplying human tissue samples, HistologiX, a histology and tissue-analysis CRO, and later Intelligent Clinical, a clinical trials operation. Rather than developing its own therapeutic pipeline, the company supports pharmaceutical, biotech, medical device, nutraceutical, and academic customers with biospecimens, tissue analytics, and clinical research services. Publicly available transaction materials indicate that Intelligent Tissue Group sold Tissue Solutions to BioIVT in 2021, while the UK holding company remains listed as an active private company. The business is best characterized as a commercial life science tools and services platform rather than a drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intelligent Tissue Group.